Promotional website intended for UK Healthcare Professionals only.
Please click here for the Lenzetto® Prescribing Information.

STARTING YOUR PATIENT ON LENZETTO®

If you are starting your patient on Lenzetto®, talking through the different aspects of treatment is essential.

A patient leaflet is available to download below to support your discussions with your patient who has been prescribed Lenzetto® and is about to start their treatment.

What do I need to know when starting
my patient on Lenzetto®?

  • Taking a break between Lenzetto® and other HRT products is not necessary1

  • One spray (90 μL) is the recommended starting dose of Lenzetto®2

  • It is possible that some symptoms may reappear whilst the patient is becoming established on a new treatment as HRT may take time to impact symptoms2

  • If after four weeks of continuous treatment with Lenzetto® symptoms persist, this may be because the dose is not high enough.2,3 The dose of Lenzetto® can be increased to two or three sprays2

  • When blood tests are being taken as part of menopause management, it might be advised that blood samples are not taken from the arm that Lenzetto® is being applied to, where estradiol levels will be higher

  • Lenzetto® should be held in the upright position when sprayed2

  • Lenzetto® should be sprayed in the same position(s) along the arm each day2

  • Lenzetto® does not need to be rubbed in after being sprayed2

  • If using sunscreen, this should be applied one hour before Lenzetto®. It should also be avoided on the part of the skin where Lenzetto® will be applied for at least one hour before or after2

  • The drug application area can be washed after one hour2

  • Patients should track their Lenzetto® doses each day using the tracker contained on the outside of the Lenzetto® box2

Correct Lenzetto® spray position

Lenzetto® should be held in the
upright position when sprayed.

Using a combination treatment regimen

Transdermal HRT is recommended for the following
specific patient populations in local guidelines5

  • Patients with poor symptom control or side effects with oral treatment
  • Stroke risks e.g. BMI>30, smoker, sedentary
  • Variable hypertension
  • History of migraines
  • Patients on hepatic enzyme inducing agents (e.g. anticonvulsants)
  • Bowel disorders or absorption problems
Disclaimer

You are now leaving Lenzetto.co.uk and will be directed to a website not owned by Gedeon Richter that contains further information on Lenzetto® (estradiol). Always refer to your GP or a Healthcare Professional.

Links to other websites are provided as a resource to our visitors.

Gedeon Richter accepts no responsibility for the content of other websites.

Disclaimer

You are now leaving Lenzetto.co.uk and will be directed to another Gedeon Richter hosted website that contains promotional information from Gedeon Richter.

Links to other websites are provided as a resource to our visitors.

NEW 20% MDS REBATE FOR DISPENSING DOCTORS
Gedeon Richter are offering a NEW 20% MDS rebate on Lenzetto® for dispensing doctors, when ordering via PSUK.
Use PIP codes:
414-9092 to order a single pack of Lenzetto®
414-9100 for a multi-pack (three units)